Psoriasis Research

Published in 2005

Case Reports

Activation of psoriasis in patients undergoing treatment with interferon-beta
Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction
Punctate palmoplantar keratoderma (Buschke-Fischer-Brauer disease) with psoriasis: a rare association showing excellent response to acitretin.
A case of sporadic pemphigus foliaceus in teenage girl with psoriasis vulgaris

Psoriasis Treatment

Psoriasis Treatment - Phototherapy or Light Therapy

Narrow-band ultraviolet B phototherapy in patients with psoriasis: for which types of psoriasis is it more effective?
Audit of the use of psoralen photochemotherapy (PUVA) and narrowband UVB phototherapy in the treatment of psoriasis.
Synchronous balneophototherapy is effective for the different clinical types of psoriasis.
A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis.
An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.

Psoriasis Treatment - Retinoids

Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis.
A review of acitretin, a systemic retinoid for the treatment of psoriasis
Topical tazarotene: a review of its use in the treatment of plaque psoriasis.

Psoriasis Treatment - TNF Blocker

Refractory psoriasis treatment with etanercept.
Infliximab Role in the treatment of psoriasis
Etanercept an effective TNF alpha-antagonist in the treatment of psoriatic arthritis and chronic plaque psoriasis
Etanercept and psoriasis, from clinical studies to real life

Psoriasis Treatment - Topical Steroids

Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients.
Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
Clobetasol propionate foam in the treatment of psoriasis
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.

Psoriasis Treatment - Immunosuppressant

Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis.
Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model.
Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series.
An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
Treatment of palmoplantar psoriasis with intramuscular alefacept.
Efalizumab for the treatment of moderate to severe plaque psoriasis.
An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis.

Psoriasis Treatment - Natural

Observation on effect of pifubing xuedu pill combined with diyin tablet in treatment of psoriasis
Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris.
A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis.
Effectiveness of kukui nut oil as a topical treatment for psoriasis.

Psoriasis Treatment - Other

Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies.
Dobesilate in the treatment of plaque psoriasis.
Long-term use of penicillin for the treatment of chronic plaque psoriasis.
Cryotherapy as a treatment for psoriasis
A new naphthalene preparation in the management of psoriasis.
Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases
Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
A clinician's paradigm in the treatment of psoriasis.
Therapeutic options in the treatment of psoriasis and atopic dermatitis.

Pathogenesis of Psoriasis

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.
Changes of ultrastructure and p-53 protein expression on the peripheral blood lymphocytes of patients with vulgar form of psoriasis after balneal therapy in resort "nunisi"
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.
RNA Polymerase II subunit 3 is retained in the cytoplasm by its interaction with HCR, the psoriasis vulgaris candidate gene product.
Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis.
Identification of differentially expressed genes in psoriasis using expression profiling approaches.
The role of metalloproteinases in psoriasis
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules.
Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.
Amphiregulin causes functional downregulation of adherens junctions in psoriasis.

Genetic Study of Psoriasis

A study of PSORS1C1 gene polymorphisms in Chinese patients with psoriasis.
Mapping and identifying genes for asthma and psoriasis
The tetratricopeptide repeat domain 7 gene is mutated in flaky skin mice: a model for psoriasis, autoimmunity, and anemia.
The genetics of psoriasis and autoimmunity
A new endogenous retroviral sequence is expressed in skin of patients with psoriasis.
Genetics of psoriasis in Iceland: evidence for linkage of subphenotypes to distinct Loci.
Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations.

Miscellaneous Articles on Psoriasis

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.
Correlation Between Macroscopic Fluorescence and Protoporphyrin IX Content in Psoriasis and Actinic Keratosis Following Application of Aminolevulinic Acid.
The psychometric properties of the psoriasis disability index in United States patients.
Diet and psoriasis: experimental data and clinical evidence.
Inpatient management of severe psoriasis.
The importance of the health education in life quality improvement in patients with psoriasis.
Soluble tumor-necrosis-factor-alpha receptor type-1 as a marker of activity of psoriasis vulgaris and effects of its treatment
Prognostic factor analysis for plaque psoriasis
Psoriasis in Norway as observed in a population-based Norwegian twin panel
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis.
Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Psoriasis SCID-mouse model
Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis.
Psoriasis--recent advances in understanding its pathogenesis and treatment.
Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.
Decision points for the initiation of systemic treatment for psoriasis.
Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects.
Psoriasis herpeticum: three cases of Kaposi's varicelliform eruption in psoriasis.

See also:
Psoriasis Overview

Psoriasis Pictures